An integrative approach for biotechnological production of next-generation anticancer agents
An integrative approach for biotechnological production of next-generation anticancer agents
批准号:
463073
负责人:
Ignea Codruta
金额:
$48.76万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-03-01 至 2027-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Taxol is one of the best anticancer drugs ever developed, used against ovarian, breast, lung and other cancers. Its effectiveness combined with anticipated further therapeutic applications has generated huge demand for the drug, which outpace current supp
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金